THE FIRST ALL-RUSSIAN PHARMACOEPIDEMIOLOGICAL STUDY «EPIDEMIOLOGY OF DRUG USE IN PREGNANT WOMEN»: BASIC RESULTS
- Autores: TKACHEVA O.N1, BEVZ A.Y.1, USHKALOVA E.A1, CHUKHAREVA N.A1
-
Afiliações:
- Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Edição: Nº 4 (2011)
- Páginas: 112-117
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246578
- ID: 246578
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Objective. To study drug-prescribing tactics for pregnant women in different regions of Russia. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Results. Most physicians have been shown to be inadequately aware of the processes of organogenesis. It has been ascertained that the physicians prescribe a wide range of drugs to pregnant women and recommend drugs with unstudied safety to a fetus and those that are contraindicated in pregnancy. The pregnant women show a low adherence to the prescribed therapy and a high self-treatment rate. Subjects and methods. A one-stage multicenter pharmacoepidemiological study was conducted. Questionnaire surveys were made among 1286 physicians of different specialties and 2324 pregnant women and puerperas. Conclusion. It is necessary to update branch standards and to introduce pregnancy management protocols according to the data of evidence-based medicine, to adjust drug use instructions in accordance with updated clinical recommendations, to elaborate educational programs for the therapy of somatic diseases in pregnancy for physicians of different specialties, to set up an effectively operating pharmacovigilance system to monitor adverse reactions occurring with drug use in pregnancy, and to initiate the creation and maintenance of registers for using drugs in pregnant women.
Palavras-chave
Texto integral
Sobre autores
O. TKACHEVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: tkacheva@rambler.ru
A. BEVZ
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
E. USHKALOVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
N. CHUKHAREVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Bibliografia
- Астахова А.В., Лепахин В.К. Лекарства. Неблагоприятные побочные реакции и контроль безопасности. — М.: Эксмо, 2008.
- Шефер К., Шпильтанн Х., Феттер К. Лекарственная терапия в период беременности и лактации. — М.: Логосфера, 2010.
- Anger G.J., Piquette-Miller M. Pharmacokinetic studies in pregnant women // Clin. Pharmacol. Ther. — 2008. — Vol. 83, № 1. — P. 184—187.
- Czeizel A.E. Epidemiological studies of congenital abnormalities in Hungary // Issues and reviews in teratology / Ed. H. Kalter-Dordrecht: Kluwer Academic Publishers, 2000. — Р. 85—124.
- Donati S., Baglio G., Spinelli A., Grandolfo M.E. Drug use in pregnancy among Italian women // Eur. J. Clin. Pharmacol. — 2000. — Vol. 56, № 4. — Р. 323—328.
- European Medicines Agency. Announcement of European Medicines Agency priorities for adverse drug reaction research. — London, 4 August 2009 Doc. Ref. EMEA/497624/2009. http://www.ema.europa.eu/pdfs/human/phv/49762409en.pdf.
- FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy. For Immediate Release: Dec. 30, 2009. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm195934.htm.
- Lo W.Y., Friedman J.M. Teratogenicity of recently introduced medications in human pregnancy // Obstet. and Gynecol. — 2002. — Vol. 100. — Р. 465—473.